RELATED STUDY

Key Findings: 

Type of Study: 

Study Result:  Inconclusive

Research Location(s): 

Year of Pub: 


Cannabinoids Studied: 

Chemotype: 

Terpenes Studied: 

Receptors Studied: 

Ligands Studied: 

DOSING DETAILS   

Study Dosing Objective:  Effective Dose,

Established Protocol:  No effective dose

Route of Administration: 

Cannabinoid Ratio:  (CBD : THC : CBC)   780 : 30 : 36    

Dosage Form:  Full-spectrum cannabis oil

Dosing Regimen:  Twice daily dosing. Total daily dose: 7.8 mg/kg of CBD 0.30 mg/kg of THC 0.36 mg/kg of CBC 0.28 mg/kg of CBGA 0.18 mg/kg of CBG other cannabinoids

Treatment Duration:  90 days

Clinical Relevance:  Pain was reduced, but it was not statistically significant. The cannabis extract product was well-tolerated.

Adverse Events:  Diarrhea was the most frequent Anxiety and hyperphagia were the only adverse events that reached statistical significance




Citation: